The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Dengue Virus Diagnostic Tests-Global Market Insights and Sales Trends 2024
Synopsis
Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
The global Dengue Virus Diagnostic Tests market size is expected to reach US$ 4188 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Dengue Virus Diagnostic Tests in various end use industries. The expanding demands from the Hospital, Research Institution and Others,, are propelling Dengue Virus Diagnostic Tests market. Dengue NS1Ag Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dengue IgG/IgM Test segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dengue Virus Diagnostic Tests, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dengue Virus Diagnostic Tests market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dengue Virus Diagnostic Tests market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dengue Virus Diagnostic Tests sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dengue Virus Diagnostic Tests covered in this report include Alere, Biogate, NovaBios Laboratories Diagnostics, Rapikit, Wondfo, BTNX, GENESIS, Boson Biotech and Adaltis, etc.
The global Dengue Virus Diagnostic Tests market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alere
Biogate
NovaBios Laboratories Diagnostics
Rapikit
Wondfo
BTNX
GENESIS
Boson Biotech
Adaltis
AccuBio Tech
Mediven
NTBIO
Global Dengue Virus Diagnostic Tests market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dengue Virus Diagnostic Tests market, Segment by Type:
Dengue NS1Ag Test
Dengue IgG/IgM Test
Dengue NS1 Ag-IgG/IgM Test
Global Dengue Virus Diagnostic Tests market, by Application
Hospital
Research Institution
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Dengue Virus Diagnostic Tests companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
The global Dengue Virus Diagnostic Tests market size is expected to reach US$ 4188 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Dengue Virus Diagnostic Tests in various end use industries. The expanding demands from the Hospital, Research Institution and Others,, are propelling Dengue Virus Diagnostic Tests market. Dengue NS1Ag Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dengue IgG/IgM Test segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dengue Virus Diagnostic Tests, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dengue Virus Diagnostic Tests market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dengue Virus Diagnostic Tests market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dengue Virus Diagnostic Tests sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dengue Virus Diagnostic Tests covered in this report include Alere, Biogate, NovaBios Laboratories Diagnostics, Rapikit, Wondfo, BTNX, GENESIS, Boson Biotech and Adaltis, etc.
The global Dengue Virus Diagnostic Tests market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alere
Biogate
NovaBios Laboratories Diagnostics
Rapikit
Wondfo
BTNX
GENESIS
Boson Biotech
Adaltis
AccuBio Tech
Mediven
NTBIO
Global Dengue Virus Diagnostic Tests market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dengue Virus Diagnostic Tests market, Segment by Type:
Dengue NS1Ag Test
Dengue IgG/IgM Test
Dengue NS1 Ag-IgG/IgM Test
Global Dengue Virus Diagnostic Tests market, by Application
Hospital
Research Institution
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Dengue Virus Diagnostic Tests companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Dengue Virus Diagnostic Tests
1.1 Dengue Virus Diagnostic Tests Market Overview
1.1.1 Dengue Virus Diagnostic Tests Product Scope
1.1.2 Dengue Virus Diagnostic Tests Market Status and Outlook
1.2 Global Dengue Virus Diagnostic Tests Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Dengue Virus Diagnostic Tests Market Size by Region (2018-2029)
1.4 Global Dengue Virus Diagnostic Tests Historic Market Size by Region (2018-2023)
1.5 Global Dengue Virus Diagnostic Tests Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Dengue Virus Diagnostic Tests Market Size (2018-2029)
1.6.1 North America Dengue Virus Diagnostic Tests Market Size (2018-2029)
1.6.2 Europe Dengue Virus Diagnostic Tests Market Size (2018-2029)
1.6.3 Asia-Pacific Dengue Virus Diagnostic Tests Market Size (2018-2029)
1.6.4 Latin America Dengue Virus Diagnostic Tests Market Size (2018-2029)
1.6.5 Middle East & Africa Dengue Virus Diagnostic Tests Market Size (2018-2029)
2 Dengue Virus Diagnostic Tests Market by Type
2.1 Introduction
2.1.1 Dengue NS1Ag Test
2.1.2 Dengue IgG/IgM Test
2.1.3 Dengue NS1 Ag-IgG/IgM Test
2.2 Global Dengue Virus Diagnostic Tests Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Dengue Virus Diagnostic Tests Historic Market Size by Type (2018-2023)
2.2.2 Global Dengue Virus Diagnostic Tests Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Dengue Virus Diagnostic Tests Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Dengue Virus Diagnostic Tests Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Dengue Virus Diagnostic Tests Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Dengue Virus Diagnostic Tests Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Dengue Virus Diagnostic Tests Revenue Breakdown by Type (2018-2029)
3 Dengue Virus Diagnostic Tests Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Research Institution
3.1.3 Others
3.2 Global Dengue Virus Diagnostic Tests Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Dengue Virus Diagnostic Tests Historic Market Size by Application (2018-2023)
3.2.2 Global Dengue Virus Diagnostic Tests Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Dengue Virus Diagnostic Tests Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Dengue Virus Diagnostic Tests Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Dengue Virus Diagnostic Tests Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Dengue Virus Diagnostic Tests Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Dengue Virus Diagnostic Tests Revenue Breakdown by Application (2018-2029)
4 Dengue Virus Diagnostic Tests Competition Analysis by Players
4.1 Global Dengue Virus Diagnostic Tests Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dengue Virus Diagnostic Tests as of 2022)
4.3 Date of Key Players Enter into Dengue Virus Diagnostic Tests Market
4.4 Global Top Players Dengue Virus Diagnostic Tests Headquarters and Area Served
4.5 Key Players Dengue Virus Diagnostic Tests Product Solution and Service
4.6 Competitive Status
4.6.1 Dengue Virus Diagnostic Tests Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Alere
5.1.1 Alere Profile
5.1.2 Alere Main Business
5.1.3 Alere Dengue Virus Diagnostic Tests Products, Services and Solutions
5.1.4 Alere Dengue Virus Diagnostic Tests Revenue (US$ Million) & (2018-2023)
5.1.5 Alere Recent Developments
5.2 Biogate
5.2.1 Biogate Profile
5.2.2 Biogate Main Business
5.2.3 Biogate Dengue Virus Diagnostic Tests Products, Services and Solutions
5.2.4 Biogate Dengue Virus Diagnostic Tests Revenue (US$ Million) & (2018-2023)
5.2.5 Biogate Recent Developments
5.3 NovaBios Laboratories Diagnostics
5.3.1 NovaBios Laboratories Diagnostics Profile
5.3.2 NovaBios Laboratories Diagnostics Main Business
5.3.3 NovaBios Laboratories Diagnostics Dengue Virus Diagnostic Tests Products, Services and Solutions
5.3.4 NovaBios Laboratories Diagnostics Dengue Virus Diagnostic Tests Revenue (US$ Million) & (2018-2023)
5.3.5 Rapikit Recent Developments
5.4 Rapikit
5.4.1 Rapikit Profile
5.4.2 Rapikit Main Business
5.4.3 Rapikit Dengue Virus Diagnostic Tests Products, Services and Solutions
5.4.4 Rapikit Dengue Virus Diagnostic Tests Revenue (US$ Million) & (2018-2023)
5.4.5 Rapikit Recent Developments
5.5 Wondfo
5.5.1 Wondfo Profile
5.5.2 Wondfo Main Business
5.5.3 Wondfo Dengue Virus Diagnostic Tests Products, Services and Solutions
5.5.4 Wondfo Dengue Virus Diagnostic Tests Revenue (US$ Million) & (2018-2023)
5.5.5 Wondfo Recent Developments
5.6 BTNX
5.6.1 BTNX Profile
5.6.2 BTNX Main Business
5.6.3 BTNX Dengue Virus Diagnostic Tests Products, Services and Solutions
5.6.4 BTNX Dengue Virus Diagnostic Tests Revenue (US$ Million) & (2018-2023)
5.6.5 BTNX Recent Developments
5.7 GENESIS
5.7.1 GENESIS Profile
5.7.2 GENESIS Main Business
5.7.3 GENESIS Dengue Virus Diagnostic Tests Products, Services and Solutions
5.7.4 GENESIS Dengue Virus Diagnostic Tests Revenue (US$ Million) & (2018-2023)
5.7.5 GENESIS Recent Developments
5.8 Boson Biotech
5.8.1 Boson Biotech Profile
5.8.2 Boson Biotech Main Business
5.8.3 Boson Biotech Dengue Virus Diagnostic Tests Products, Services and Solutions
5.8.4 Boson Biotech Dengue Virus Diagnostic Tests Revenue (US$ Million) & (2018-2023)
5.8.5 Boson Biotech Recent Developments
5.9 Adaltis
5.9.1 Adaltis Profile
5.9.2 Adaltis Main Business
5.9.3 Adaltis Dengue Virus Diagnostic Tests Products, Services and Solutions
5.9.4 Adaltis Dengue Virus Diagnostic Tests Revenue (US$ Million) & (2018-2023)
5.9.5 Adaltis Recent Developments
5.10 AccuBio Tech
5.10.1 AccuBio Tech Profile
5.10.2 AccuBio Tech Main Business
5.10.3 AccuBio Tech Dengue Virus Diagnostic Tests Products, Services and Solutions
5.10.4 AccuBio Tech Dengue Virus Diagnostic Tests Revenue (US$ Million) & (2018-2023)
5.10.5 AccuBio Tech Recent Developments
5.11 Mediven
5.11.1 Mediven Profile
5.11.2 Mediven Main Business
5.11.3 Mediven Dengue Virus Diagnostic Tests Products, Services and Solutions
5.11.4 Mediven Dengue Virus Diagnostic Tests Revenue (US$ Million) & (2018-2023)
5.11.5 Mediven Recent Developments
5.12 NTBIO
5.12.1 NTBIO Profile
5.12.2 NTBIO Main Business
5.12.3 NTBIO Dengue Virus Diagnostic Tests Products, Services and Solutions
5.12.4 NTBIO Dengue Virus Diagnostic Tests Revenue (US$ Million) & (2018-2023)
5.12.5 NTBIO Recent Developments
6 North America
6.1 North America Dengue Virus Diagnostic Tests Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Dengue Virus Diagnostic Tests Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Dengue Virus Diagnostic Tests Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Dengue Virus Diagnostic Tests Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Dengue Virus Diagnostic Tests Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Dengue Virus Diagnostic Tests Market Dynamics
11.1 Dengue Virus Diagnostic Tests Industry Trends
11.2 Dengue Virus Diagnostic Tests Market Drivers
11.3 Dengue Virus Diagnostic Tests Market Challenges
11.4 Dengue Virus Diagnostic Tests Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
